dalteparin has been researched along with Ornithine Carbamoyltransferase Deficiency Disease in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Ornithine Carbamoyltransferase Deficiency Disease: An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venkateswaran, L | 1 |
| Scaglia, F | 1 |
| McLin, V | 1 |
| Hertel, P | 1 |
| Shchelochkov, OA | 1 |
| Karpen, S | 1 |
| Mahoney, D | 1 |
| Yee, DL | 1 |
1 other study available for dalteparin and Ornithine Carbamoyltransferase Deficiency Disease
| Article | Year |
|---|---|
Ornithine transcarbamylase deficiency: a possible risk factor for thrombosis.
Topics: Anticoagulants; Compartment Syndromes; Enoxaparin; Humans; Infant; Infant, Newborn; Male; Ornithine | 2009 |